The global neutropenia treatment market size reached US$ 14.51 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 20.19 Billion by 2028, exhibiting a CAGR of 5.66% during 2022-2028. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.
Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.
The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the treatment. This includes colony-stimulating factors, antibiotics, antifungals and antivirals. According to the report, colony-stimulating factors represented the largest segment.
The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the distribution channel. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.
Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.
Neutropenia Treatment Market Trends:
The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each segment of the global neutropenia treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on treatment and distribution channel.Treatment Insights:
- Colony-Stimulating Factors
- Antibiotics
- Antifungals
- Antivirals
The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the treatment. This includes colony-stimulating factors, antibiotics, antifungals and antivirals. According to the report, colony-stimulating factors represented the largest segment.
Distribution channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the distribution channel. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
Regional Insights:
- North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report:
- How has the global neutropenia treatment market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global neutropenia treatment market?
- What are the key regional markets?
- Which countries represent the most attractive neutropenia treatment markets?
- What is the breakup of the market based on the treatment?
- What is the breakup of the market based on the distribution channel?
- What is the competitive structure of the global neutropenia treatment market?
- Who are the key players/companies in the global neutropenia treatment market?
Table of Contents
1 Preface2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neutropenia Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment
6.1 Colony-Stimulating Factors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Antibiotics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Antifungals
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Antivirals
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacies
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 BeyondSpring Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Pfizer Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Sandoz Inc. (Novartis AG)
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 SWOT Analysis
13.3.6 Spectrum Pharmaceuticals Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Teva Pharmaceutical Industries Ltd.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Viatris Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
- Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2022
Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2022
Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2022
Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities
Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis
Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Neutropenia Treatment Market: Competitive Structure
Table 6: Global: Neutropenia Treatment Market: Key Players
Companies Mentioned
- Amgen Inc.
- BeyondSpring Inc.
- Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
- Pfizer Inc.
- Sandoz Inc. (Novartis AG)
- Spectrum Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Methodology
LOADING...
